Education
About Us
Working with TipRanks
Follow Us
Omnicell (OMCL)
NASDAQ:OMCL
OMCL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$25.12 - $55.75
Previous CloseN/A
Volume97.52K
Average Volume (3M)432.70K
Market Cap
$1.78B
Enterprise Value$2.07B
Total Cash (Recent Filing)$369.20M
Total Debt (Recent Filing)$371.84M
Price to Earnings (P/E)143.8
Beta0.21
Next Earnings
Apr 24, 2025EPS Estimate
0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.26
Shares Outstanding46,759,415
10 Day Avg. Volume439,941
30 Day Avg. Volume432,699
Standard Deviation0.14
R-Squared0.10
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.67
Price to Cash Flow (P/CF)19.60
P/FCF Ratio32.00
Enterprise Value/Market Cap1.16
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.14
Enterprise Value/Ebitda44.68
Forecast
1Y Price Target
$56.20Price Target Upside48.95% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
---
Omnicell News
PremiumCompany Announcements
Omnicell’s Earnings Call Highlights Growth Amid Challenges
PremiumCompany Announcements
Omnicell Reports Strong Q4 2024 Financial Results
---
Bulls Say, Bears Say
Bulls Say
Client StickinessNew products adding revenue visibility and client stickiness, with most XT Amplify bookings being 5–10-year agreements.
Robotic Revenue GrowthOMCL is tracking to ~$71MM in total robotic revenue for 2025, suggesting a potential $10MM year-over-year improvement.
Bears Say
Product Bookings GuidanceOMCL ended the day 11% lower as investors responded to soft 2025 product bookings guidance.
---
Ownership Overview
1.98% Insiders
30.03% Mutual Funds
17.54% Other Institutional Investors
16.29% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OMCL FAQ
What was Omnicell’s price range in the past 12 months?
Omnicell lowest stock price was $25.12 and its highest was $55.74 in the past 12 months.
What is Omnicell’s market cap?
Omnicell’s market cap is $1.78B.
When is Omnicell’s upcoming earnings report date?
Omnicell’s upcoming earnings report date is Apr 24, 2025 which is in 51 days.
How were Omnicell’s earnings last quarter?
Omnicell released its earnings results on Feb 06, 2025. The company reported $0.6 earnings per share for the quarter, beating the consensus estimate of $0.584 by $0.016.
Is Omnicell overvalued?
According to Wall Street analysts Omnicell’s price is currently Undervalued.
Does Omnicell pay dividends?
Omnicell does not currently pay dividends.
What is Omnicell’s EPS estimate?
Omnicell’s EPS estimate is 0.21.
How many shares outstanding does Omnicell have?
Omnicell has 46,759,415 shares outstanding.
What happened to Omnicell’s price movement after its last earnings report?
Omnicell reported an EPS of $0.6 in its last earnings report, beating expectations of $0.584. Following the earnings report the stock price went down -11.154%.
Which hedge fund is a major shareholder of Omnicell?
Currently, no hedge funds are holding shares in OMCL
---
Omnicell Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$56.20 (48.95% Upside)
$56.20 (48.95% Upside)
Blogger Sentiment
Bullish
OMCL Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 16.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $567.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 3.4%
Last 30 Days ▲ 3.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
43.13%
12-Months-Change
Fundamentals
Return on Equity
1.03%
Trailing 12-Months
Asset Growth
-4.76%
Trailing 12-Months
Company Description
Omnicell
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence; platform and interoperability; central pharmacy dispensing; medication adherence; population health; and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Mountain View, CA.
---
OMCL Company Deck
---
OMCL Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong financial performance with revenue growth, profitability, and significant customer wins. However, challenges include a decreased cash balance and flat product bookings outlook for 2025.Read More>---
OMCL Stock 12 Month Forecast
Average Price Target
$56.20
▲(48.95% Upside)
Technical Analysis
Best Analysts Covering OMCL
1 Year
1 Year Success Rate
9/18 ratings generated profit
1 Year Average Return
+10.45%
reiterated a buy rating 26 days ago
Copying Bill Sutherland's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +10.45% per trade.
---